Iii Med. Abteilung For Hematologie and Onkologie Hanuscfhkrankenhaus

Vienna 01140

0 studies enrolling now · 1 studies all time

What they study most

MPN (Myeloproliferative Neoplasms)

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203) — Completed